-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LxO06LFrM3ckIQ/zh/5Tu6M9b93rNA4WIwX9tX0XVrZiHBAXhKIVHIjYBp979WTl NrqkIgaYY2THEEc5vzGTYQ== 0001127602-09-010568.txt : 20090504 0001127602-09-010568.hdr.sgml : 20090504 20090504202054 ACCESSION NUMBER: 0001127602-09-010568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090430 FILED AS OF DATE: 20090504 DATE AS OF CHANGE: 20090504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAY RUSSELL T CENTRAL INDEX KEY: 0001225960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 09795176 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-04-30 0000850693 ALLERGAN INC AGN 0001225960 RAY RUSSELL T 2525 DUPONT DRIVE IRVINE CA 92612 1 Common Stock 2009-04-30 4 A 0 14400 A 25200 D Nonemployee Director Stock Option (Right to Buy) 46.66 2009-04-30 4 A 0 11400 0 A 2019-04-30 Common Stock 11400 11400 D Restricted Stock granted to Nonemployee Directors under the Allergan, Inc. 2008 Incentive Award Plan. Stock vests at the rate of 4,800 shares each calendar year upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant. The per share exercise price is the closing price of Allergan's common stock as of the date of grant. Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant. /s/ Matthew J. Maletta, Attorney-in-Fact for Russell T. Ray 2009-05-04 -----END PRIVACY-ENHANCED MESSAGE-----